You are here

Press Releases

Press Release | December 19, 2019
Mark Brager
mbrager@advamed.org

WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker today released the following statement on Senate passage of full repeal of the medical device excise tax:

“On behalf of the entire medtech industry and the patients we serve, we thank the Senate for passing legislation to repeal the medical device excise tax once and for all. Without the leadership of Majority Leader Mitch McConnell and Minority Leader Chuck Schumer, as well as that of Sen. Pat Toomey and all the cosponsors of the device tax repeal legislation, the industry would be facing massive job losses and cuts to the very research and development we need to save and improve patients’ lives. Patients are the real winners here today.

“We look forward to the president signing this legislation into law.”

# # #

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.

Press Release | December 17, 2019

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker on the U.S. House of Representatives’ vote to repeal the medical device excise tax:

Press Release | December 16, 2019

WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker released the following statement on the announcement by congressional leadership of a funding agreement that includes full repeal of the medical device excise tax. The agreement is expected to be passed this week by Congress and signed into law by President Trump:

Press Release | December 13, 2019

WASHINGTON, D.C. – In an op-ed published today in Morning Consult, AdvaMed President and CEO Scott Whitaker urges Congress to act before the medical device excise tax comes back into effect Jan. 1.

Press Release | December 12, 2019

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement today from President and CEO Scott Whitaker regarding the U.S. Senate’s confirmation of Dr. Stephen Hahn to serve as the new FDA Commissioner:

“Dr. Hahn is an excellent choice to lead FDA, and we congratulate him on his swift and overwhelming bipartisan confirmation. During the confirmation process, Dr. Hahn demonstrated his deep understanding of the agency’s mission to protect and promote the public health and the role of innovation in improving patient care. His background as a physician, researcher and administrator will serve the American people well at this vital agency. We look forward to working with him on behalf of the patients our industry serves.”

Press Release | December 12, 2019

WASHINGTON, D.C. – In today’s Wall Street Journal, the editorial board wrote that Congress “should stop a return of the destructive” medical device excise tax scheduled to go into effect on Jan. 1.

Press Release | December 11, 2019

WASHINGTON, D.C. – More than half of medical device company employees expect reinstatement of the medical device excise tax in 2020 to lead both to job losses and cuts to research and development programs, according to a new survey by a top industry and business news publisher, SmartBrief.

Press Release | December 10, 2019

Washington, D.C. – The Advanced Medical Technology Association (AdvaMed) today issued the following statement from President and CEO Scott Whitaker on the newly upgraded United States-Mexico-Canada Agreement (USMCA):

Press Release | December 10, 2019

WASHINGTON, D.C. – The Medical Alley Association yesterday released a survey of its membership demonstrating that if the medical device tax is reinstated on Jan. 1, 2020, 83 percent of medtech companies will decrease R&D spending, 67 percent will delay or forego planned hiring, and 47 percent will delay plans to physically expand their business.

Press Release | December 9, 2019

WASHINGTON, D.C. – More than 1,000 medical technology companies started after the device tax was last in effect (from 2013-15) will pay the excise tax for the first time in January if Congress fails to repeal or delay the tax, according to an AdvaMed analysis of the industry. 

Pages